Global BCG Vaccine for Tuberculosis (TB) Market Research Report 2024, Forecast to 2032
Report Overview
BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
The global BCG Vaccine for Tuberculosis (TB) market size was estimated at USD 373.90 million in 2023 and is projected to reach USD 610.56 million by 2032, exhibiting a CAGR of 5.60% during the forecast period.
North America BCG Vaccine for Tuberculosis (TB) market size was estimated at USD 107.01 million in 2023, at a CAGR of 4.80% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global BCG Vaccine for Tuberculosis (TB) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global BCG Vaccine for Tuberculosis (TB) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the BCG Vaccine for Tuberculosis (TB) market in any manner.
Global BCG Vaccine for Tuberculosis (TB) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundaз?o Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Market Segmentation (by Type)
Immune Type
Therapy Type
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the BCG Vaccine for Tuberculosis (TB) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of BCG Vaccine for Tuberculosis (TB), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
The global BCG Vaccine for Tuberculosis (TB) market size was estimated at USD 373.90 million in 2023 and is projected to reach USD 610.56 million by 2032, exhibiting a CAGR of 5.60% during the forecast period.
North America BCG Vaccine for Tuberculosis (TB) market size was estimated at USD 107.01 million in 2023, at a CAGR of 4.80% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global BCG Vaccine for Tuberculosis (TB) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global BCG Vaccine for Tuberculosis (TB) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the BCG Vaccine for Tuberculosis (TB) market in any manner.
Global BCG Vaccine for Tuberculosis (TB) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundaз?o Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Market Segmentation (by Type)
Immune Type
Therapy Type
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the BCG Vaccine for Tuberculosis (TB) Market
- Overview of the regional outlook of the BCG Vaccine for Tuberculosis (TB) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the BCG Vaccine for Tuberculosis (TB) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of BCG Vaccine for Tuberculosis (TB), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of BCG Vaccine for Tuberculosis (TB)
1.2 Key Market Segments
1.2.1 BCG Vaccine for Tuberculosis (TB) Segment by Type
1.2.2 BCG Vaccine for Tuberculosis (TB) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET COMPETITIVE LANDSCAPE
3.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Manufacturers (2019-2024)
3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Manufacturers (2019-2024)
3.3 BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global BCG Vaccine for Tuberculosis (TB) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers BCG Vaccine for Tuberculosis (TB) Sales Sites, Area Served, Product Type
3.6 BCG Vaccine for Tuberculosis (TB) Market Competitive Situation and Trends
3.6.1 BCG Vaccine for Tuberculosis (TB) Market Concentration Rate
3.6.2 Global 5 and 10 Largest BCG Vaccine for Tuberculosis (TB) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BCG VACCINE FOR TUBERCULOSIS (TB) INDUSTRY CHAIN ANALYSIS
4.1 BCG Vaccine for Tuberculosis (TB) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BCG VACCINE FOR TUBERCULOSIS (TB) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2019-2024)
6.3 Global BCG Vaccine for Tuberculosis (TB) Market Size Market Share by Type (2019-2024)
6.4 Global BCG Vaccine for Tuberculosis (TB) Price by Type (2019-2024)
7 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global BCG Vaccine for Tuberculosis (TB) Market Sales by Application (2019-2024)
7.3 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) by Application (2019-2024)
7.4 Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
8 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET CONSUMPTION BY REGION
8.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region
8.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region
8.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region
8.2 North America
8.2.1 North America BCG Vaccine for Tuberculosis (TB) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe BCG Vaccine for Tuberculosis (TB) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America BCG Vaccine for Tuberculosis (TB) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET PRODUCTION BY REGION
9.1 Global Production of BCG Vaccine for Tuberculosis (TB) by Region (2019-2024)
9.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2019-2024)
9.3 Global BCG Vaccine for Tuberculosis (TB) Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America BCG Vaccine for Tuberculosis (TB) Production
9.4.1 North America BCG Vaccine for Tuberculosis (TB) Production Growth Rate (2019-2024)
9.4.2 North America BCG Vaccine for Tuberculosis (TB) Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe BCG Vaccine for Tuberculosis (TB) Production
9.5.1 Europe BCG Vaccine for Tuberculosis (TB) Production Growth Rate (2019-2024)
9.5.2 Europe BCG Vaccine for Tuberculosis (TB) Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan BCG Vaccine for Tuberculosis (TB) Production (2019-2024)
9.6.1 Japan BCG Vaccine for Tuberculosis (TB) Production Growth Rate (2019-2024)
9.6.2 Japan BCG Vaccine for Tuberculosis (TB) Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China BCG Vaccine for Tuberculosis (TB) Production (2019-2024)
9.7.1 China BCG Vaccine for Tuberculosis (TB) Production Growth Rate (2019-2024)
9.7.2 China BCG Vaccine for Tuberculosis (TB) Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck BCG Vaccine for Tuberculosis (TB) Basic Information
10.1.2 Merck BCG Vaccine for Tuberculosis (TB) Product Overview
10.1.3 Merck BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck BCG Vaccine for Tuberculosis (TB) SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Basic Information
10.2.2 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Overview
10.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.2.4 Sanofi Pasteur Business Overview
10.2.5 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) SWOT Analysis
10.2.6 Sanofi Pasteur Recent Developments
10.3 Japan BCG Lab
10.3.1 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Basic Information
10.3.2 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Overview
10.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.3.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) SWOT Analysis
10.3.5 Japan BCG Lab Business Overview
10.3.6 Japan BCG Lab Recent Developments
10.4 China National Biotec
10.4.1 China National Biotec BCG Vaccine for Tuberculosis (TB) Basic Information
10.4.2 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Overview
10.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.4.4 China National Biotec Business Overview
10.4.5 China National Biotec Recent Developments
10.5 AJ Vaccines
10.5.1 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Basic Information
10.5.2 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Overview
10.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.5.4 AJ Vaccines Business Overview
10.5.5 AJ Vaccines Recent Developments
10.6 Serum Institute of India
10.6.1 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Basic Information
10.6.2 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Overview
10.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.6.4 Serum Institute of India Business Overview
10.6.5 Serum Institute of India Recent Developments
10.7 Intervax
10.7.1 Intervax BCG Vaccine for Tuberculosis (TB) Basic Information
10.7.2 Intervax BCG Vaccine for Tuberculosis (TB) Product Overview
10.7.3 Intervax BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.7.4 Intervax Business Overview
10.7.5 Intervax Recent Developments
10.8 GSBPL
10.8.1 GSBPL BCG Vaccine for Tuberculosis (TB) Basic Information
10.8.2 GSBPL BCG Vaccine for Tuberculosis (TB) Product Overview
10.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.8.4 GSBPL Business Overview
10.8.5 GSBPL Recent Developments
10.9 Statens Serum Institute
10.9.1 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Basic Information
10.9.2 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Overview
10.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.9.4 Statens Serum Institute Business Overview
10.9.5 Statens Serum Institute Recent Developments
10.10 Biomed Lublin
10.10.1 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Basic Information
10.10.2 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Overview
10.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.10.4 Biomed Lublin Business Overview
10.10.5 Biomed Lublin Recent Developments
10.11 ANLIS Malbran
10.11.1 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Basic Information
10.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Overview
10.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.11.4 ANLIS Malbran Business Overview
10.11.5 ANLIS Malbran Recent Developments
10.12 Fundaз?o Ataulpho de Paiva
10.12.1 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Basic Information
10.12.2 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Overview
10.12.3 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.12.4 Fundaз?o Ataulpho de Paiva Business Overview
10.12.5 Fundaз?o Ataulpho de Paiva Recent Developments
10.13 BB-NCIPD
10.13.1 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Basic Information
10.13.2 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Overview
10.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.13.4 BB-NCIPD Business Overview
10.13.5 BB-NCIPD Recent Developments
10.14 Taj Pharmaceuticals
10.14.1 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Basic Information
10.14.2 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Overview
10.14.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.14.4 Taj Pharmaceuticals Business Overview
10.14.5 Taj Pharmaceuticals Recent Developments
10.15 Bio Farma
10.15.1 Bio Farma BCG Vaccine for Tuberculosis (TB) Basic Information
10.15.2 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Overview
10.15.3 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.15.4 Bio Farma Business Overview
10.15.5 Bio Farma Recent Developments
10.16 Microgen
10.16.1 Microgen BCG Vaccine for Tuberculosis (TB) Basic Information
10.16.2 Microgen BCG Vaccine for Tuberculosis (TB) Product Overview
10.16.3 Microgen BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.16.4 Microgen Business Overview
10.16.5 Microgen Recent Developments
10.17 Torlakinstitut
10.17.1 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Basic Information
10.17.2 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Overview
10.17.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.17.4 Torlakinstitut Business Overview
10.17.5 Torlakinstitut Recent Developments
10.18 Institut Pasteur de Tunis
10.18.1 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Basic Information
10.18.2 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Overview
10.18.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.18.4 Institut Pasteur de Tunis Business Overview
10.18.5 Institut Pasteur de Tunis Recent Developments
10.19 IVAC
10.19.1 IVAC BCG Vaccine for Tuberculosis (TB) Basic Information
10.19.2 IVAC BCG Vaccine for Tuberculosis (TB) Product Overview
10.19.3 IVAC BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.19.4 IVAC Business Overview
10.19.5 IVAC Recent Developments
11 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET FORECAST BY REGION
11.1 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast
11.2 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country
11.2.3 Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region
11.2.4 South America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of BCG Vaccine for Tuberculosis (TB) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of BCG Vaccine for Tuberculosis (TB) by Type (2025-2032)
12.1.2 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of BCG Vaccine for Tuberculosis (TB) by Type (2025-2032)
12.2 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Application (2025-2032)
12.2.1 Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) Forecast by Application
12.2.2 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of BCG Vaccine for Tuberculosis (TB)
1.2 Key Market Segments
1.2.1 BCG Vaccine for Tuberculosis (TB) Segment by Type
1.2.2 BCG Vaccine for Tuberculosis (TB) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET COMPETITIVE LANDSCAPE
3.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Manufacturers (2019-2024)
3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Manufacturers (2019-2024)
3.3 BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global BCG Vaccine for Tuberculosis (TB) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers BCG Vaccine for Tuberculosis (TB) Sales Sites, Area Served, Product Type
3.6 BCG Vaccine for Tuberculosis (TB) Market Competitive Situation and Trends
3.6.1 BCG Vaccine for Tuberculosis (TB) Market Concentration Rate
3.6.2 Global 5 and 10 Largest BCG Vaccine for Tuberculosis (TB) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BCG VACCINE FOR TUBERCULOSIS (TB) INDUSTRY CHAIN ANALYSIS
4.1 BCG Vaccine for Tuberculosis (TB) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BCG VACCINE FOR TUBERCULOSIS (TB) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2019-2024)
6.3 Global BCG Vaccine for Tuberculosis (TB) Market Size Market Share by Type (2019-2024)
6.4 Global BCG Vaccine for Tuberculosis (TB) Price by Type (2019-2024)
7 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global BCG Vaccine for Tuberculosis (TB) Market Sales by Application (2019-2024)
7.3 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) by Application (2019-2024)
7.4 Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
8 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET CONSUMPTION BY REGION
8.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region
8.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region
8.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region
8.2 North America
8.2.1 North America BCG Vaccine for Tuberculosis (TB) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe BCG Vaccine for Tuberculosis (TB) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America BCG Vaccine for Tuberculosis (TB) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET PRODUCTION BY REGION
9.1 Global Production of BCG Vaccine for Tuberculosis (TB) by Region (2019-2024)
9.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2019-2024)
9.3 Global BCG Vaccine for Tuberculosis (TB) Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America BCG Vaccine for Tuberculosis (TB) Production
9.4.1 North America BCG Vaccine for Tuberculosis (TB) Production Growth Rate (2019-2024)
9.4.2 North America BCG Vaccine for Tuberculosis (TB) Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe BCG Vaccine for Tuberculosis (TB) Production
9.5.1 Europe BCG Vaccine for Tuberculosis (TB) Production Growth Rate (2019-2024)
9.5.2 Europe BCG Vaccine for Tuberculosis (TB) Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan BCG Vaccine for Tuberculosis (TB) Production (2019-2024)
9.6.1 Japan BCG Vaccine for Tuberculosis (TB) Production Growth Rate (2019-2024)
9.6.2 Japan BCG Vaccine for Tuberculosis (TB) Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China BCG Vaccine for Tuberculosis (TB) Production (2019-2024)
9.7.1 China BCG Vaccine for Tuberculosis (TB) Production Growth Rate (2019-2024)
9.7.2 China BCG Vaccine for Tuberculosis (TB) Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck BCG Vaccine for Tuberculosis (TB) Basic Information
10.1.2 Merck BCG Vaccine for Tuberculosis (TB) Product Overview
10.1.3 Merck BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck BCG Vaccine for Tuberculosis (TB) SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Basic Information
10.2.2 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Overview
10.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.2.4 Sanofi Pasteur Business Overview
10.2.5 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) SWOT Analysis
10.2.6 Sanofi Pasteur Recent Developments
10.3 Japan BCG Lab
10.3.1 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Basic Information
10.3.2 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Overview
10.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.3.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) SWOT Analysis
10.3.5 Japan BCG Lab Business Overview
10.3.6 Japan BCG Lab Recent Developments
10.4 China National Biotec
10.4.1 China National Biotec BCG Vaccine for Tuberculosis (TB) Basic Information
10.4.2 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Overview
10.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.4.4 China National Biotec Business Overview
10.4.5 China National Biotec Recent Developments
10.5 AJ Vaccines
10.5.1 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Basic Information
10.5.2 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Overview
10.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.5.4 AJ Vaccines Business Overview
10.5.5 AJ Vaccines Recent Developments
10.6 Serum Institute of India
10.6.1 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Basic Information
10.6.2 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Overview
10.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.6.4 Serum Institute of India Business Overview
10.6.5 Serum Institute of India Recent Developments
10.7 Intervax
10.7.1 Intervax BCG Vaccine for Tuberculosis (TB) Basic Information
10.7.2 Intervax BCG Vaccine for Tuberculosis (TB) Product Overview
10.7.3 Intervax BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.7.4 Intervax Business Overview
10.7.5 Intervax Recent Developments
10.8 GSBPL
10.8.1 GSBPL BCG Vaccine for Tuberculosis (TB) Basic Information
10.8.2 GSBPL BCG Vaccine for Tuberculosis (TB) Product Overview
10.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.8.4 GSBPL Business Overview
10.8.5 GSBPL Recent Developments
10.9 Statens Serum Institute
10.9.1 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Basic Information
10.9.2 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Overview
10.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.9.4 Statens Serum Institute Business Overview
10.9.5 Statens Serum Institute Recent Developments
10.10 Biomed Lublin
10.10.1 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Basic Information
10.10.2 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Overview
10.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.10.4 Biomed Lublin Business Overview
10.10.5 Biomed Lublin Recent Developments
10.11 ANLIS Malbran
10.11.1 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Basic Information
10.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Overview
10.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.11.4 ANLIS Malbran Business Overview
10.11.5 ANLIS Malbran Recent Developments
10.12 Fundaз?o Ataulpho de Paiva
10.12.1 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Basic Information
10.12.2 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Overview
10.12.3 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.12.4 Fundaз?o Ataulpho de Paiva Business Overview
10.12.5 Fundaз?o Ataulpho de Paiva Recent Developments
10.13 BB-NCIPD
10.13.1 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Basic Information
10.13.2 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Overview
10.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.13.4 BB-NCIPD Business Overview
10.13.5 BB-NCIPD Recent Developments
10.14 Taj Pharmaceuticals
10.14.1 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Basic Information
10.14.2 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Overview
10.14.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.14.4 Taj Pharmaceuticals Business Overview
10.14.5 Taj Pharmaceuticals Recent Developments
10.15 Bio Farma
10.15.1 Bio Farma BCG Vaccine for Tuberculosis (TB) Basic Information
10.15.2 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Overview
10.15.3 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.15.4 Bio Farma Business Overview
10.15.5 Bio Farma Recent Developments
10.16 Microgen
10.16.1 Microgen BCG Vaccine for Tuberculosis (TB) Basic Information
10.16.2 Microgen BCG Vaccine for Tuberculosis (TB) Product Overview
10.16.3 Microgen BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.16.4 Microgen Business Overview
10.16.5 Microgen Recent Developments
10.17 Torlakinstitut
10.17.1 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Basic Information
10.17.2 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Overview
10.17.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.17.4 Torlakinstitut Business Overview
10.17.5 Torlakinstitut Recent Developments
10.18 Institut Pasteur de Tunis
10.18.1 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Basic Information
10.18.2 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Overview
10.18.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.18.4 Institut Pasteur de Tunis Business Overview
10.18.5 Institut Pasteur de Tunis Recent Developments
10.19 IVAC
10.19.1 IVAC BCG Vaccine for Tuberculosis (TB) Basic Information
10.19.2 IVAC BCG Vaccine for Tuberculosis (TB) Product Overview
10.19.3 IVAC BCG Vaccine for Tuberculosis (TB) Product Market Performance
10.19.4 IVAC Business Overview
10.19.5 IVAC Recent Developments
11 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET FORECAST BY REGION
11.1 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast
11.2 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country
11.2.3 Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region
11.2.4 South America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of BCG Vaccine for Tuberculosis (TB) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of BCG Vaccine for Tuberculosis (TB) by Type (2025-2032)
12.1.2 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of BCG Vaccine for Tuberculosis (TB) by Type (2025-2032)
12.2 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Application (2025-2032)
12.2.1 Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) Forecast by Application
12.2.2 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. BCG Vaccine for Tuberculosis (TB) Market Size Comparison by Region (M USD)
Table 5. Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global BCG Vaccine for Tuberculosis (TB) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine for Tuberculosis (TB) as of 2022)
Table 10. Global Market BCG Vaccine for Tuberculosis (TB) Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers BCG Vaccine for Tuberculosis (TB) Sales Sites and Area Served
Table 12. Manufacturers BCG Vaccine for Tuberculosis (TB) Product Type
Table 13. Global BCG Vaccine for Tuberculosis (TB) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of BCG Vaccine for Tuberculosis (TB)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. BCG Vaccine for Tuberculosis (TB) Market Challenges
Table 22. Global BCG Vaccine for Tuberculosis (TB) Sales by Type (K MT)
Table 23. Global BCG Vaccine for Tuberculosis (TB) Market Size by Type (M USD)
Table 24. Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) by Type (2019-2024)
Table 25. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2019-2024)
Table 26. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) by Type (2019-2024)
Table 27. Global BCG Vaccine for Tuberculosis (TB) Market Size Share by Type (2019-2024)
Table 28. Global BCG Vaccine for Tuberculosis (TB) Price (USD/MT) by Type (2019-2024)
Table 29. Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) by Application
Table 30. Global BCG Vaccine for Tuberculosis (TB) Market Size by Application
Table 31. Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2019-2024) & (K MT)
Table 32. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2019-2024)
Table 33. Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2019-2024) & (M USD)
Table 34. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application (2019-2024)
Table 35. Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
Table 36. Global BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (K MT)
Table 37. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2019-2024)
Table 38. North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (K MT)
Table 39. Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (K MT)
Table 41. South America BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (K MT)
Table 43. Global BCG Vaccine for Tuberculosis (TB) Production (K MT) by Region (2019-2024)
Table 44. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Region (2019-2024)
Table 45. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2019-2024)
Table 46. Global BCG Vaccine for Tuberculosis (TB) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America BCG Vaccine for Tuberculosis (TB) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe BCG Vaccine for Tuberculosis (TB) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan BCG Vaccine for Tuberculosis (TB) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China BCG Vaccine for Tuberculosis (TB) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Merck BCG Vaccine for Tuberculosis (TB) Basic Information
Table 52. Merck BCG Vaccine for Tuberculosis (TB) Product Overview
Table 53. Merck BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Merck Business Overview
Table 55. Merck BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 56. Merck Recent Developments
Table 57. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Basic Information
Table 58. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Overview
Table 59. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Sanofi Pasteur Business Overview
Table 61. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 62. Sanofi Pasteur Recent Developments
Table 63. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Basic Information
Table 64. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Overview
Table 65. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 67. Japan BCG Lab Business Overview
Table 68. Japan BCG Lab Recent Developments
Table 69. China National Biotec BCG Vaccine for Tuberculosis (TB) Basic Information
Table 70. China National Biotec BCG Vaccine for Tuberculosis (TB) Product Overview
Table 71. China National Biotec BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. China National Biotec Business Overview
Table 73. China National Biotec Recent Developments
Table 74. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Basic Information
Table 75. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Overview
Table 76. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. AJ Vaccines Business Overview
Table 78. AJ Vaccines Recent Developments
Table 79. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Basic Information
Table 80. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Overview
Table 81. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Serum Institute of India Business Overview
Table 83. Serum Institute of India Recent Developments
Table 84. Intervax BCG Vaccine for Tuberculosis (TB) Basic Information
Table 85. Intervax BCG Vaccine for Tuberculosis (TB) Product Overview
Table 86. Intervax BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Intervax Business Overview
Table 88. Intervax Recent Developments
Table 89. GSBPL BCG Vaccine for Tuberculosis (TB) Basic Information
Table 90. GSBPL BCG Vaccine for Tuberculosis (TB) Product Overview
Table 91. GSBPL BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. GSBPL Business Overview
Table 93. GSBPL Recent Developments
Table 94. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Basic Information
Table 95. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Overview
Table 96. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Statens Serum Institute Business Overview
Table 98. Statens Serum Institute Recent Developments
Table 99. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Basic Information
Table 100. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Overview
Table 101. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Biomed Lublin Business Overview
Table 103. Biomed Lublin Recent Developments
Table 104. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Basic Information
Table 105. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Overview
Table 106. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. ANLIS Malbran Business Overview
Table 108. ANLIS Malbran Recent Developments
Table 109. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Basic Information
Table 110. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Overview
Table 111. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Fundaз?o Ataulpho de Paiva Business Overview
Table 113. Fundaз?o Ataulpho de Paiva Recent Developments
Table 114. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Basic Information
Table 115. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Overview
Table 116. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. BB-NCIPD Business Overview
Table 118. BB-NCIPD Recent Developments
Table 119. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Basic Information
Table 120. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Overview
Table 121. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Taj Pharmaceuticals Business Overview
Table 123. Taj Pharmaceuticals Recent Developments
Table 124. Bio Farma BCG Vaccine for Tuberculosis (TB) Basic Information
Table 125. Bio Farma BCG Vaccine for Tuberculosis (TB) Product Overview
Table 126. Bio Farma BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Bio Farma Business Overview
Table 128. Bio Farma Recent Developments
Table 129. Microgen BCG Vaccine for Tuberculosis (TB) Basic Information
Table 130. Microgen BCG Vaccine for Tuberculosis (TB) Product Overview
Table 131. Microgen BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Microgen Business Overview
Table 133. Microgen Recent Developments
Table 134. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Basic Information
Table 135. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Overview
Table 136. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Torlakinstitut Business Overview
Table 138. Torlakinstitut Recent Developments
Table 139. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Basic Information
Table 140. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Overview
Table 141. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Institut Pasteur de Tunis Business Overview
Table 143. Institut Pasteur de Tunis Recent Developments
Table 144. IVAC BCG Vaccine for Tuberculosis (TB) Basic Information
Table 145. IVAC BCG Vaccine for Tuberculosis (TB) Product Overview
Table 146. IVAC BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. IVAC Business Overview
Table 148. IVAC Recent Developments
Table 149. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Region (2025-2032) & (K MT)
Table 150. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region (2025-2032) & (M USD)
Table 151. North America BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2032) & (K MT)
Table 152. North America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2032) & (M USD)
Table 153. Europe BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2032) & (K MT)
Table 154. Europe BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2032) & (M USD)
Table 155. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales Forecast by Region (2025-2032) & (K MT)
Table 156. Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region (2025-2032) & (M USD)
Table 157. South America BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2032) & (K MT)
Table 158. South America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2032) & (M USD)
Table 159. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Consumption Forecast by Country (2025-2032) & (Units)
Table 160. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2032) & (M USD)
Table 161. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Type (2025-2032) & (K MT)
Table 162. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Type (2025-2032) & (M USD)
Table 163. Global BCG Vaccine for Tuberculosis (TB) Price Forecast by Type (2025-2032) & (USD/MT)
Table 164. Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) Forecast by Application (2025-2032)
Table 165. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. BCG Vaccine for Tuberculosis (TB) Market Size Comparison by Region (M USD)
Table 5. Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global BCG Vaccine for Tuberculosis (TB) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine for Tuberculosis (TB) as of 2022)
Table 10. Global Market BCG Vaccine for Tuberculosis (TB) Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers BCG Vaccine for Tuberculosis (TB) Sales Sites and Area Served
Table 12. Manufacturers BCG Vaccine for Tuberculosis (TB) Product Type
Table 13. Global BCG Vaccine for Tuberculosis (TB) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of BCG Vaccine for Tuberculosis (TB)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. BCG Vaccine for Tuberculosis (TB) Market Challenges
Table 22. Global BCG Vaccine for Tuberculosis (TB) Sales by Type (K MT)
Table 23. Global BCG Vaccine for Tuberculosis (TB) Market Size by Type (M USD)
Table 24. Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) by Type (2019-2024)
Table 25. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2019-2024)
Table 26. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) by Type (2019-2024)
Table 27. Global BCG Vaccine for Tuberculosis (TB) Market Size Share by Type (2019-2024)
Table 28. Global BCG Vaccine for Tuberculosis (TB) Price (USD/MT) by Type (2019-2024)
Table 29. Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) by Application
Table 30. Global BCG Vaccine for Tuberculosis (TB) Market Size by Application
Table 31. Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2019-2024) & (K MT)
Table 32. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2019-2024)
Table 33. Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2019-2024) & (M USD)
Table 34. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application (2019-2024)
Table 35. Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
Table 36. Global BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (K MT)
Table 37. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2019-2024)
Table 38. North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (K MT)
Table 39. Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (K MT)
Table 41. South America BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (K MT)
Table 43. Global BCG Vaccine for Tuberculosis (TB) Production (K MT) by Region (2019-2024)
Table 44. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Region (2019-2024)
Table 45. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2019-2024)
Table 46. Global BCG Vaccine for Tuberculosis (TB) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America BCG Vaccine for Tuberculosis (TB) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe BCG Vaccine for Tuberculosis (TB) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan BCG Vaccine for Tuberculosis (TB) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China BCG Vaccine for Tuberculosis (TB) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Merck BCG Vaccine for Tuberculosis (TB) Basic Information
Table 52. Merck BCG Vaccine for Tuberculosis (TB) Product Overview
Table 53. Merck BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Merck Business Overview
Table 55. Merck BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 56. Merck Recent Developments
Table 57. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Basic Information
Table 58. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Overview
Table 59. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Sanofi Pasteur Business Overview
Table 61. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 62. Sanofi Pasteur Recent Developments
Table 63. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Basic Information
Table 64. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Overview
Table 65. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 67. Japan BCG Lab Business Overview
Table 68. Japan BCG Lab Recent Developments
Table 69. China National Biotec BCG Vaccine for Tuberculosis (TB) Basic Information
Table 70. China National Biotec BCG Vaccine for Tuberculosis (TB) Product Overview
Table 71. China National Biotec BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. China National Biotec Business Overview
Table 73. China National Biotec Recent Developments
Table 74. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Basic Information
Table 75. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Overview
Table 76. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. AJ Vaccines Business Overview
Table 78. AJ Vaccines Recent Developments
Table 79. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Basic Information
Table 80. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Overview
Table 81. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Serum Institute of India Business Overview
Table 83. Serum Institute of India Recent Developments
Table 84. Intervax BCG Vaccine for Tuberculosis (TB) Basic Information
Table 85. Intervax BCG Vaccine for Tuberculosis (TB) Product Overview
Table 86. Intervax BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Intervax Business Overview
Table 88. Intervax Recent Developments
Table 89. GSBPL BCG Vaccine for Tuberculosis (TB) Basic Information
Table 90. GSBPL BCG Vaccine for Tuberculosis (TB) Product Overview
Table 91. GSBPL BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. GSBPL Business Overview
Table 93. GSBPL Recent Developments
Table 94. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Basic Information
Table 95. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Overview
Table 96. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Statens Serum Institute Business Overview
Table 98. Statens Serum Institute Recent Developments
Table 99. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Basic Information
Table 100. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Overview
Table 101. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Biomed Lublin Business Overview
Table 103. Biomed Lublin Recent Developments
Table 104. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Basic Information
Table 105. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Overview
Table 106. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. ANLIS Malbran Business Overview
Table 108. ANLIS Malbran Recent Developments
Table 109. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Basic Information
Table 110. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Overview
Table 111. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Fundaз?o Ataulpho de Paiva Business Overview
Table 113. Fundaз?o Ataulpho de Paiva Recent Developments
Table 114. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Basic Information
Table 115. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Overview
Table 116. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. BB-NCIPD Business Overview
Table 118. BB-NCIPD Recent Developments
Table 119. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Basic Information
Table 120. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Overview
Table 121. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Taj Pharmaceuticals Business Overview
Table 123. Taj Pharmaceuticals Recent Developments
Table 124. Bio Farma BCG Vaccine for Tuberculosis (TB) Basic Information
Table 125. Bio Farma BCG Vaccine for Tuberculosis (TB) Product Overview
Table 126. Bio Farma BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Bio Farma Business Overview
Table 128. Bio Farma Recent Developments
Table 129. Microgen BCG Vaccine for Tuberculosis (TB) Basic Information
Table 130. Microgen BCG Vaccine for Tuberculosis (TB) Product Overview
Table 131. Microgen BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Microgen Business Overview
Table 133. Microgen Recent Developments
Table 134. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Basic Information
Table 135. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Overview
Table 136. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Torlakinstitut Business Overview
Table 138. Torlakinstitut Recent Developments
Table 139. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Basic Information
Table 140. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Overview
Table 141. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Institut Pasteur de Tunis Business Overview
Table 143. Institut Pasteur de Tunis Recent Developments
Table 144. IVAC BCG Vaccine for Tuberculosis (TB) Basic Information
Table 145. IVAC BCG Vaccine for Tuberculosis (TB) Product Overview
Table 146. IVAC BCG Vaccine for Tuberculosis (TB) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. IVAC Business Overview
Table 148. IVAC Recent Developments
Table 149. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Region (2025-2032) & (K MT)
Table 150. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region (2025-2032) & (M USD)
Table 151. North America BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2032) & (K MT)
Table 152. North America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2032) & (M USD)
Table 153. Europe BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2032) & (K MT)
Table 154. Europe BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2032) & (M USD)
Table 155. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales Forecast by Region (2025-2032) & (K MT)
Table 156. Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region (2025-2032) & (M USD)
Table 157. South America BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2032) & (K MT)
Table 158. South America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2032) & (M USD)
Table 159. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Consumption Forecast by Country (2025-2032) & (Units)
Table 160. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2032) & (M USD)
Table 161. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Type (2025-2032) & (K MT)
Table 162. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Type (2025-2032) & (M USD)
Table 163. Global BCG Vaccine for Tuberculosis (TB) Price Forecast by Type (2025-2032) & (USD/MT)
Table 164. Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) Forecast by Application (2025-2032)
Table 165. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of BCG Vaccine for Tuberculosis (TB)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD), 2019-2032
Figure 5. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) (2019-2032)
Figure 6. Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. BCG Vaccine for Tuberculosis (TB) Market Size by Country (M USD)
Figure 11. BCG Vaccine for Tuberculosis (TB) Sales Share by Manufacturers in 2023
Figure 12. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers in 2023
Figure 13. BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market BCG Vaccine for Tuberculosis (TB) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by BCG Vaccine for Tuberculosis (TB) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global BCG Vaccine for Tuberculosis (TB) Market Share by Type
Figure 18. Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Type (2019-2024)
Figure 19. Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Type in 2023
Figure 20. Market Size Share of BCG Vaccine for Tuberculosis (TB) by Type (2019-2024)
Figure 21. Market Size Market Share of BCG Vaccine for Tuberculosis (TB) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application
Figure 24. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2019-2024)
Figure 25. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application in 2023
Figure 26. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application (2019-2024)
Figure 27. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application in 2023
Figure 28. Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
Figure 29. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2019-2024)
Figure 30. North America BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 32. U.S. BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada BCG Vaccine for Tuberculosis (TB) Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico BCG Vaccine for Tuberculosis (TB) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 37. Germany BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region in 2023
Figure 44. China BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (K MT)
Figure 50. South America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 51. Brazil BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global BCG Vaccine for Tuberculosis (TB) Production Market Share by Region (2019-2024)
Figure 62. North America BCG Vaccine for Tuberculosis (TB) Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe BCG Vaccine for Tuberculosis (TB) Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan BCG Vaccine for Tuberculosis (TB) Production (K MT) Growth Rate (2019-2024)
Figure 65. China BCG Vaccine for Tuberculosis (TB) Production (K MT) Growth Rate (2019-2024)
Figure 66. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global BCG Vaccine for Tuberculosis (TB) Market Share Forecast by Type (2025-2032)
Figure 70. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Application (2025-2032)
Figure 71. Global BCG Vaccine for Tuberculosis (TB) Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of BCG Vaccine for Tuberculosis (TB)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD), 2019-2032
Figure 5. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) (2019-2032)
Figure 6. Global BCG Vaccine for Tuberculosis (TB) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. BCG Vaccine for Tuberculosis (TB) Market Size by Country (M USD)
Figure 11. BCG Vaccine for Tuberculosis (TB) Sales Share by Manufacturers in 2023
Figure 12. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers in 2023
Figure 13. BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market BCG Vaccine for Tuberculosis (TB) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by BCG Vaccine for Tuberculosis (TB) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global BCG Vaccine for Tuberculosis (TB) Market Share by Type
Figure 18. Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Type (2019-2024)
Figure 19. Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Type in 2023
Figure 20. Market Size Share of BCG Vaccine for Tuberculosis (TB) by Type (2019-2024)
Figure 21. Market Size Market Share of BCG Vaccine for Tuberculosis (TB) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application
Figure 24. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2019-2024)
Figure 25. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application in 2023
Figure 26. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application (2019-2024)
Figure 27. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application in 2023
Figure 28. Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
Figure 29. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2019-2024)
Figure 30. North America BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 32. U.S. BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada BCG Vaccine for Tuberculosis (TB) Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico BCG Vaccine for Tuberculosis (TB) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 37. Germany BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region in 2023
Figure 44. China BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (K MT)
Figure 50. South America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 51. Brazil BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global BCG Vaccine for Tuberculosis (TB) Production Market Share by Region (2019-2024)
Figure 62. North America BCG Vaccine for Tuberculosis (TB) Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe BCG Vaccine for Tuberculosis (TB) Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan BCG Vaccine for Tuberculosis (TB) Production (K MT) Growth Rate (2019-2024)
Figure 65. China BCG Vaccine for Tuberculosis (TB) Production (K MT) Growth Rate (2019-2024)
Figure 66. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global BCG Vaccine for Tuberculosis (TB) Market Share Forecast by Type (2025-2032)
Figure 70. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Application (2025-2032)
Figure 71. Global BCG Vaccine for Tuberculosis (TB) Market Share Forecast by Application (2025-2032)
